Aurora Cannabis Inc (NASDAQ:ACB) CEO Miguel Martin discussed the company's record earnings and strategic global expansion on Benzinga's Cannabis Insider podcast. Aurora reported its fifth consecutive quarter of adjusted EBITDA positivity, a 41% increase in international medical cannabis revenue, and a significant reduction in losses from the previous year. The acquisition of MedReleaf Australia is highlighted as a key move in Aurora's strategy, aiming to lead in high-margin, clinician-led markets. Aurora boasts a strong financial position with over $200 million in the balance sheet and no debt, focusing on innovation, quality, and patient care in the medical cannabis sector.